Benzinga - by Lisa Levin, Benzinga Editor.
U.S. stock futures traded mostly lower this morning, with the Dow Jones futures falling around 50 points on Tuesday.
Shares of AVITA Medical, Inc. (NASDAQ: RCEL) shares dipped in pre-market trading after the company cut its FY23 revenue guidance.
AVITA Medical revised its FY23 revenue guidance from $51 million-$53 million to $49.5 million-$50.5 million, according to data from Benzinga Pro.
AVITA Medical shares fell 10.9% to $11.17 in pre-market trading
Here are some other big stocks recording losses in today’s pre-market trading session.
- Sibanye Stillwater Limited (NYSE: SBSW) shares tumbled 24.2% to $3.94 in pre-market trading.
- MorphoSys AG (NASDAQ: MOR) shares dipped 23.4% to $4.49 in pre-market trading. The company’s Phase 3 study of pelabresib in myelofibrosis demonstrated statistically significant improvement in spleen volume reduction and strong positive trend in symptom reduction.
- reAlpha Tech Corp. (NASDAQ: AIRE) fell 8.2% to $6.60 in pre-market trading after declining around 23% on Monday. The company recently filed a prospectus for the offering of up to 1.67 million common units at a price of $12 per unit.
- Vertex Energy, Inc. (NASDAQ: VTNR) shares fell 4.7% to $3.66 in pre-market trading.
- iQIYI, Inc. (NASDAQ: IQ) shares declined 4.4% to $5.00 in pre-market trading following third-quarter results.
- Burford Capital Limited (NYSE: BUR) fell 3.4% to $13.74 in pre-market trading.
- Trip.com Group Limited (NASDAQ: TCOM) fell 3.2% to $35.50 in pre-market trading after reporting third-quarter results.
Now Read This: NVIDIA, Best Buy And 3 Stocks To Watch Heading Into Tuesday
Don’t forget to check out our premarket coverage here
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.